Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?
Leon Sass126.73%1,086,238$2.29MInsider
Steen Knudsen14.58%124,976$263.70kInsider
Renaissance Technologies LLC4.53%38,786$81.84kInstitution
Geode Capital Management LLC3.43%29,433$62.10kInstitution
Morgan Stanley3.35%28,713$60.58kInstitution
Duncan Moore2.65%22,672$47.84kInsider
Bridgeway Capital Management LLC2.33%20,000$42.20kInstitution
Thomas Jensen2.08%17,841$37.64kInsider
State Street Corp1.51%12,974$27.38kInstitution
Two Sigma Securities LLC1.46%12,534$26.45kInstitution

1 of 2

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENSC4.17%95.83%Net BuyingNet Buying
TCBP1.15%98.85%Net Buying

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 16.93% institutional shareholders, 146.83% Allarity Therapeutics insiders, and 0.00% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 126.73% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.96M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.